Lyell Immunopharma News

Lyell Immunopharma Analyst Ratings

BenzingaMar 1 04:19

HC Wainwright & Co. Maintains Buy on Lyell Immunopharma, Lowers Price Target to $8

BenzingaNov 9, 2023 20:38

Lyell Immunopharma Analyst Ratings

BenzingaNov 9, 2023 20:37

Promising Financial and Clinical Prospects: A Comprehensive Buy Rating Analysis for Lyell Immunopharma

TipRanksNov 9, 2023 19:46

JP Morgan Cuts Lyell to Neutral, Pending Data for Cell Therapy Platform

Seeking AlphaAug 29, 2023 05:41

JP Morgan Downgrades Lyell Immunopharma to Neutral, Lowers Price Target to $5

BenzingaAug 28, 2023 16:48

Lyell Immunopharma Analyst Ratings

BenzingaAug 28, 2023 16:47

H.C. Wainwright Reaffirms Their Buy Rating on Lyell Immunopharma (LYEL)

TipRanksAug 9, 2023 18:35

HC Wainwright & Co. Reiterates Buy on Lyell Immunopharma, Maintains $9 Price Target

BenzingaMay 5, 2023 18:55

Lyell Immunopharma (LYEL) Receives a Buy From H.C. Wainwright

TipRanksMay 5, 2023 18:36

HC Wainwright Adjusts Price Target on Lyell Immunopharma to $9 From $11, Maintains Buy Rating

MT NewswiresMar 2, 2023 20:37

HC Wainwright & Co. Maintains Buy on Lyell Immunopharma, Lowers Price Target to $9

BenzingaMar 2, 2023 19:20

Morgan Stanley Adjusts Lyell Immunopharma's Price Target to $4 From $7, Maintains Equal Weight Rating

MT NewswiresJan 25, 2023 00:40

Morgan Stanley Sticks to Its Hold Rating for Lyell Immunopharma (LYEL)

TipRanksJan 25, 2023 00:30

Lyell Immunopharma Analyst Ratings

Benzinga Analyst RatingsJan 24, 2023 22:06

Morgan Stanley Maintains Equal-Weight on Lyell Immunopharma, Lowers Price Target to $4

Benzinga Real-time NewsJan 24, 2023 22:06

Lyell Immunopharma Analyst Ratings

Benzinga Analyst RatingsNov 14, 2022 19:26

Morgan Stanley Downgrades Lyell Immunopharma to Equal-Weight, Lowers Price Target to $7

Benzinga Real-time NewsNov 14, 2022 19:26

Lyell Immunopharma Analyst Ratings

Benzinga Analyst RatingsNov 12, 2022 02:33